The decrease in microalbuminuria with carvedilol therapy is not enhanced by concurrent use of a statin.
Bell
David S H
DS
McGill
Janet B
JB
Fonseca
Vivian A
VA
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000419:Albuminuria / Q000188:drug therapy*; D002227:Carbazoles / Q000008:administration & dosage*; D000077261:Carvedilol; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage*; D011412:Propanolamines / Q000008:administration & dosage*
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011412:Propanolamines; D000077261:Carvedilol